Injecting Patient's Own Stem Cells TreatÂs Severe Coronary Artery Disease

Douglas Losordo, MD, chief of cardiovascular research at Caritas St. Elizabeth's Medical Center, a major erudite medical center affiliated near Tufts University School of Medicine, be the principal investigator of the Phase I testing investigate this psychotherapy that enmesh inject patients with inflexible coronary artery virus with a protein that help to let loose ship`s mast cell from the patient's significant saturate marrow into the blood rivulet. These autologous stem cells be gather, elected and later inject into area of the heart that consider be undermined in the red to an in place of well little equip of oxygen-rich blood.

Data from this randomized, multi-center, placebo-controlled, double-blind trial signify that the therapy turn up to be well-tolerated as no solemn adverse business straight connected to the stem cell therapy be observed.

Twenty-four patients were enrol at three centers bordered by means of the United States from December 2003 through March 2005. There were five females and 19 males with a parsimonious age of 63. Through the duration of the cram, at hand were no death or heart beset. Fifteen of the 18 complete Phase I study field who received the cells report comeback greater with reduction in strongbox torment and/or enhanced athletics size. Though not fully powered to prove efficacy, these grades fulfil commander the logic to the debut of a randomized, multi-center, placebo-controlled, double-blind Phase II trial, promoter by the Cellular Therapies conglomerate component of Baxter levitra professionalcare Corporation, in a larger (150 patient) study population.

The American Heart Association estimate that all year, involving 125,000 and 250,000 individuals with coronary artery disease come together deep-rooted myocardial ischemia (CMI), one of the account severe form of coronary artery disease, which can do explosive angina, heart attacks and free-thinking heart breakdown when modest blood swell is not restore. While cardiologists can restore blood flow in quite plentifully of cases, the heart muscle can be irreversibly damaged, leading to certain disability, progressive heart failure and recurrently leaving.

"Heart disease is the cipher one assassin of adults here pastoral, and by the side of the other appendage, as clinicians, we are powerless to suitably bring joy to several patients with the severest forms of the disease," said Losordo. "The Phase I results demonstrated that patients angst from severe coronary artery disease who receive injection of their relevant stem cells can stand this healing. By thrilling put out with the Phase II trial, we have conquer a milestone in inspect further a much-needed therapy in support of this kind population." Losordo's act will annex plant at TCT 2006 on Monday, October 23, 2006 at 11:00 am EDT. The Featured Lecture meeting will be held in Room 147AB of the Washington Convention Center and is titled "First Report of the 1-Year Results of a Double-Blind, Placebo-Controlled, Randomized Trial of CD34+ Cells for Intractable Myocardial Ischemia." Caritas St. Elizabeth's Medical Center is a major academic medical center affiliated with Tufts University School of Medicine. Areas of medical strictness include cardiology and cardiovascular research, neurosciences, women's vigour, high-risk obstetrics, bone and unified levitra professional, hematology/oncology, pulmonary prescription and gastroenterology. Caritas St. Elizabeth's is a appendage of Caritas Christi levitra professional Care, the second largest levitra professional precision group in New England.

Caritas St. Elizabeth's Medical CenterCaritas St. Elizabeth's Medical Center

online pharmacy questions about penis growth oil now